rss icon

Perrigo Co. plc plans to “separate” its generic drug business that’s faced significant price pressure and generated lower sales.

Published in In the News
Monday, 08 January 2018 10:43

Perrigo names new CEO

Uwe Rohrhoff, a veteran pharmaceutical industry executive who previously ran Germany’s Gerresheimer AG, was named today as the new president and CEO at Perrigo Co. plc.

Published in In the News

Perrigo Co. plc (NYSE: PRGO) said federal investigators executed a search of its corporate office as part of a broader, ongoing investigation of drug pricing in the pharmaceutical industry.

Published in In the News

With its share price down more than 13 percent since the Brexit vote, appliance maker Whirlpool Corp. looked to calm investors this morning by reaffirming its guidance for the 2015 fiscal year.

Published in In the News

Stock prices of West Michigan’s publicly traded companies tumbled on Friday as Wall Street succumbed to the uncertainty caused by the U.K.’s decision to exit the European Union.

Published in In the News

Mylan this morning said Perrigo shareholders tendered 40 percent of outstanding shares to Mylan, or about 58 million shares, which was well short of the 50 percent needed and caused the takeover bid to lapse.

Published in In the News

Both sides in Mylan N.V.’s hostile takeover bid for Perrigo Co plc now claim in lawsuits that the other party is intentionally misleading investors.

Published in In the News
Wednesday, 09 September 2015 10:42

Mylan launching hostile bid Sept. 14 for Perrigo

Mylan N.V., nearly five months after publicly stating it wants to acquire the company, plans to take a buyout proposal, now estimated at $27.1 billion, directly to Perrigo Co. plc shareholders Sept. 14 in a hostile takeover bid.

Published in In the News

Mylan N.V. remains committed to acquiring Perrigo Co. plc and plans to present its case directly to shareholders, setting up a potential shareholder fight for control of the company.

Published in In the News
Wednesday, 08 April 2015 12:40

Mylan makes $28.9 billion bid for Perrigo

A British pharmaceutical maker wants to buy Perrigo Co. plc in a cash-and-stock deal worth as much as $30 billion.

Published in In the News
Page 1 of 2

Breaking News

September 2018
26 27 28 29 30 31 1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 1 2 3 4 5 6

Follow MiBiz